Leading from the front, compact management structure, commitment to quality,
adoption of
latest technologies & revolutionary employee engagement policies have been the
foundation
of our continuous success.
Making way from Punjab to become one of the most trusted brands in agro-chemical
companies, Safex has expanded many folds. We have increased our turnover 13 times
and
operating profit 17 times in the last 10 years. Yet, we continue to grow while
embracing
new challenges, expanding boundaries and creating new opportunities.
With business spanning 17 states, Safex today is a 500+ crore company having a
dealer
count of more than 10,000 providing employment to 1000+ members. Hence, Safex is a
pioneer
at implementing management principles with utmost sincerity to get the best possible
outcomes.
At the core of our progress is our motto: Let’s fly together!
ChrysCapital
Established in 1999, ChrysCapital is a leading India focused investment firm,
managing
approximately $4 billion across eight funds. With over 90 investments since 1999,
the
group has valuable experience investing across a breadth of sectors. ChrysCapital
has
developed a strong track record, delivering over $5.5 billion from over 70 exits.
The
ChrysCapital funds are ranked in the top decile of global private equity funds of
similar
vintage. ChrysCapital VIII, LLC is the eighth fund of the group that was raised in
late
2018 with a corpus of over $850 million.
ChrysCapital believes that partnerships with excellent management teams in
attractive
sectors are the foundation of successful private equity investing. The integrity and
execution capability of management are the two most important factors in the
evaluation of
an investment opportunity. Our aim is to be a trustworthy financial partner and a
stable
long-term investor leveraging our deep relationships in the industry.
One of the factors that differentiates ChrysCapital is the ability to scout and help
its
portfolio companies think through M&A targets. ChrysCapital played an instrumental
role in
Intas’ $770 mn acquisition of Actavis UK / Ireland. ChrysCapital got Intas into the
acquisition process, leveraged industry expertise and relationship with founders to
convince them to pursue the acquisition and eventually helped win the deal for
Intas. This
was the 2nd largest outbound acquisition by an Indian pharma company and propelled
them to
become the second largest generics player in the UK.
Another differentiating factor is ChrysCapital’s industry leading track record,
amongst
private equity peers, of assisting portfolio companies to go public through an IPO –
ChrysCapital has taken 10 companies public such as AU Small Finance Bank, Eris
Lifesciences, Redington, M&M Financial Services, to name a few, and has provided
valuable
inputs to each of these in their IPO journey as well as in their new life as a
publicly-listed company.
Team/Board of Directors
Mr. S.K. Chaudhary, Chairman, Safex Group
Mr. S.K. Chaudhary, Chairman of Safex Group, is a first-generation entrepreneur whose visionary leadership has been the cornerstone of the company’s journey. With over four decades of experience and a Master’s degree in Agricultural Sciences, he has played a defining role in shaping Safex into one of India’s leading multinational agrochemical companies.
As Chairman, Mr. Chaudhary continues to provide strategic oversight and guidance, anchoring the Group’s values and long-term vision. His deep understanding of agriculture, coupled with an unwavering focus on sustainability and innovation, has helped Safex navigate industry cycles, expand its footprint, and build lasting trust with stakeholders.
Beyond business, his greatest legacy lies in the people he has nurtured. A mentor to the leadership team and over 1,500 employees across the Group, he has instilled a culture of integrity, resilience, and accountability. His calm, grounded approach and ability to lead with both empathy and conviction have been instrumental in fostering a unified and purpose-driven organization.
Even today, Mr. Chaudhary remains the guiding force behind Safex’s continued evolution—his wisdom and values echo across the Group as it moves confidently into the future.
Mr. Rajesh Jindal, Vice Chairman, Safex Group
With over 35 years of entrepreneurial experience in the agrochemical sector, Mr. Rajesh Jindal has been a driving force behind Safex Group’s operational excellence and growth. As Vice Chairman, he brings a sharp eye for detail, a deep understanding of trading dynamics, and an unwavering focus on execution.
Mr. Jindal has revolutionized Safex’s logistics and inventory systems, ensuring seamless product availability even in the most remote corners of India. His introduction of the Self-Audit programme has embedded a culture of accountability and continuous improvement across the organization, empowering individuals to evaluate their work with both precision and purpose.
Beyond operations, he leads the human resources function, where his implementation of a profit-based appraisal system has inspired a performance-driven culture aligned with business goals. His ability to blend discipline with empowerment has fostered a workforce that takes pride in ownership and execution.
Mr. Jindal’s strategic foresight, grounded leadership, and commitment to reliability continue to play a pivotal role in Safex Group’s journey towards excellence.
Mr. Neeraj Jindal, Managing Director, Safex Group
Mr. Neeraj Jindal, a Chemical Engineer with an MBA from SP Jain, is the driving force behind Safex Group’s innovation engine and global growth. As Managing Director, he combines deep technical expertise with sharp strategic acumen to lead high-impact initiatives across R&D, international business, and operational transformation.
A turnaround specialist with a passion for execution, Mr. Jindal has played a key role in advancing Safex’s manufacturing and formulation capabilities. His leadership led to the successful commercialization of Renofluthrin—India’s first indigenously developed novel mosquito control molecule—marking a milestone in the country’s chemical innovation journey.
He also heads Safex’s CDMO business across India and the UK, partnering with global innovators to fast-track product commercialization and build resilient supply chains. His focus on technology-led growth, customer-centricity, and sustainability has positioned Safex as a trusted partner across global markets.
From pioneering R&D initiatives to driving global expansion and championing EHS practices, Mr. Jindal’s relentless pursuit of excellence continues to shape Safex Group’s future as a forward-thinking, agile, and internationally respected enterprise.
Mr. Piyush Jindal, Joint Managing Director, Safex Group
Mr. Piyush Jindal, a Commerce graduate from Hindu College, Delhi University, and a Chartered Accountant, has been one of the key architects of Safex Group’s exponential rise since 2010. As Joint Managing Director, he has donned multiple hats—driving strategic finance, business expansion, and digital transformation with equal conviction and impact.
Under his leadership, Safex’s market valuation has surged 80x, reflecting his sharp capital allocation mindset and unwavering focus on sustainable growth. Piyush has successfully led four major acquisitions, including a landmark international deal—among the largest in the agchem sector—and has raised over $90 million from leading private equity investors. His ability to forge strong investor relationships and unlock strategic capital has been instrumental in scaling the Group’s global footprint.
Piyush’s expertise goes beyond finance—he has played a central role in defining and executing the Group’s long-term strategy, steering high-stakes decisions on M&A, governance, and global expansion. As a turnaround specialist, he is known for navigating complexity with clarity and aligning business goals with bold, yet pragmatic, execution plans.
He is also the brain behind Safex’s digital transformation, having built an integrated tech platform combining SAP, AI/ML, business analytics, and mobile-first field force automation. This initiative has dramatically improved operational efficiency, visibility, and decision-making across the organization—setting a new benchmark for tech adoption in the agrochemical industry.
His cross-functional leadership across finance, technology, and strategy continues to drive Safex’s evolution into a globally admired, future-ready enterprise.
Other Directors
Raghav Ramdev
Nominee Director
Raghav Ramdev has joined the Board as a nominee director from Chrys Capital. He holds an MBA from the Management Development Institute, Gurgaon, and a Bachelor’s degree in Chemical Engineering from Baroda University. Having joined Chrys Capital in Sep 2003, he’s a Managing Director at the Firm currently and leads investments in the Manufacturing and Healthcare sectors. Previously, he was with the global research division at McKinsey & Company. Prior to Chrys Capital, Mr. Ramdev worked with the global research division at McKinsey & Company.
Savan Rashmikant Godiawala
Independent Director
He holds a PhD in Management, is a Chartered Accountant, and holds a Bachelor's in Law & Commerce. Additionally, he is a qualified Insolvency Professional and has a Postgraduate Diploma in Counselling, Psychology, and Psychotherapy. With over 30 years of experience in Investment Banking and Financial Advisory, including 19 years at Deloitte India, he retired as a Partner from Deloitte Touche Tohmatsu India LLP in March 2024. Mr. Godiawala has been actively involved in various professional and industry associations and has served on committees of the Ahmedabad Management Association, FICCI, and the Ahmedabad branch of the Institute of Chartered Accountants of India. He is also a visiting faculty member at the Indian Institute of Management Ahmedabad (since 2008) and IIT Gandhinagar (since 2024). He co-authored a book on 'Business Taxation' published by McGraw Hill Education and was honored as a “Gem of the CA Profession” by the Institute of Chartered Accountants of India.
Prem Chand
Independent Director
He holds a PhD from BITS Pilani, M.Tech from IIT Madras, Naval Electrical Specialization from INS Valsura, Jamnagar, B.Sc., a Software Engineering Course from Selenia Rome, and a DBA from ISB, Hyderabad. Currently, he is associated with Mitkat Advisory as a consultant. Mr. Chand has previously served in the Indian Navy as Lieutenant (Assistant Director) to Commodore (Additional Director General). He has also held senior roles as Vice-President at Mahindra British Telecom/Tech Mahindra and as Consultant/Director at Codenomicon Software.
Bipinchandra Solanki
Independent Director
He is a highly accomplished Agribusiness Leader with over 42 years of experience in agrochemicals, seeds, and biotech traits. With a proven track record in driving business growth and innovation, Mr. Solanki has held diverse roles in sales, business development, and strategic leadership. His key strengths include extensive international experience across India, Pakistan, Bangladesh, Sri Lanka, and Indonesia, as well as expertise in strategic execution within the agrochemical, seed, and biotech sectors. He also has a deep understanding of key crops like Corn, Cotton, Sorghum, Pearl Millet, and Hybrid Rice. Mr. Solanki has previously served as Managing Director at Syngenta, CEO at DevGen, Director at Monsanto, and Deputy Managing Director at Mahyco Monsanto Biotech Pvt Ltd.
Manisha Raghunath Kadagathur
Independent Director
With over 25 years of experience in HR leadership, she holds a Bachelor's degree in Math and Computer Science and an MBA. She is also a Professional Certified Coach from the International Coaching Federation (ICF). Currently, she serves as a Senior Advisor at ANAROCK Property Consultants. Ms. Kadagathur has previously held key HR roles at renowned companies including FMCG, GSK, Aon, Bharti AXA, AEGON Religare Life Insurance, Zephyr Consulting Services, and Vini Cosmetics.
Yogesh Kapur
Independent Director
Mr. Yogesh Kapur is a Fellow Chartered Accountant (FCA) with over 39 years of experience in the financial services sector. He has held key roles at leading institutions like HDFC, HSBC, Axis Bank, and Enam Securities. An expert in investment banking, he has advised corporates on acquisitions, restructuring, and strategic initiatives, while also working closely with the Government of India on public sector divestments. Mr. Kapur has also led international assignments for USAID and the World Bank and contributed to regulatory committees on global listings and convertible bonds.
News
Financial Statements
Policies
Disclosures
Annual Returns
Leading from the front, compact management structure, commitment to quality,
adoption of
latest technologies & revolutionary employee engagement policies have been the
foundation
of our continuous success.
Making way from Punjab to become one of the most trusted brands in agro-chemical
companies, Safex has expanded many folds. We have increased our turnover 13 times
and
operating profit 17 times in the last 10 years. Yet, we continue to grow while
embracing
new challenges, expanding boundaries and creating new opportunities.
With business spanning 17 states, Safex today is a 500+ crore company having a
dealer
count of more than 10,000 providing employment to 1000+ members. Hence, Safex is a
pioneer
at implementing management principles with utmost sincerity to get the best possible
outcomes.
At the core of our progress is our motto: Let’s fly together!
Team/Boards of Directors
Mr. S.K. Chaudhary
Chairman, Safex Group
Mr. S.K. Chaudhary, Chairman of Safex Group, is a first-generation entrepreneur whose visionary leadership has been the cornerstone of the company’s journey. With over four decades of experience and a Master’s degree in Agricultural Sciences, he has played a defining role in shaping Safex into one of India’s leading multinational agrochemical companies.
As Chairman, Mr. Chaudhary continues to provide strategic oversight and guidance, anchoring the Group’s values and long-term vision. His deep understanding of agriculture, coupled with an unwavering focus on sustainability and innovation, has helped Safex navigate industry cycles, expand its footprint, and build lasting trust with stakeholders.
Beyond business, his greatest legacy lies in the people he has nurtured. A mentor to the leadership team and over 1,500 employees across the Group, he has instilled a culture of integrity, resilience, and accountability. His calm, grounded approach and ability to lead with both empathy and conviction have been instrumental in fostering a unified and purpose-driven organization.
Even today, Mr. Chaudhary remains the guiding force behind Safex’s continued evolution—his wisdom and values echo across the Group as it moves confidently into the future.
Mr. Rajesh Jindal
Vice Chairman, Safex Group
With over 35 years of entrepreneurial experience in the agrochemical sector, Mr. Rajesh Jindal has been a driving force behind Safex Group’s operational excellence and growth. As Vice Chairman, he brings a sharp eye for detail, a deep understanding of trading dynamics, and an unwavering focus on execution.
Mr. Jindal has revolutionized Safex’s logistics and inventory systems, ensuring seamless product availability even in the most remote corners of India. His introduction of the Self-Audit programme has embedded a culture of accountability and continuous improvement across the organization, empowering individuals to evaluate their work with both precision and purpose.
Beyond operations, he leads the human resources function, where his implementation of a profit-based appraisal system has inspired a performance-driven culture aligned with business goals. His ability to blend discipline with empowerment has fostered a workforce that takes pride in ownership and execution.
Mr. Jindal’s strategic foresight, grounded leadership, and commitment to reliability continue to play a pivotal role in Safex Group’s journey towards excellence.
Mr. Neeraj Jindal
Managing Director, Safex Group
Mr. Neeraj Jindal, a Chemical Engineer with an MBA from SP Jain, is the driving force behind Safex Group’s innovation engine and global growth. As Managing Director, he combines deep technical expertise with sharp strategic acumen to lead high-impact initiatives across R&D, international business, and operational transformation.
A turnaround specialist with a passion for execution, Mr. Jindal has played a key role in advancing Safex’s manufacturing and formulation capabilities. His leadership led to the successful commercialization of Renofluthrin—India’s first indigenously developed novel mosquito control molecule—marking a milestone in the country’s chemical innovation journey.
He also heads Safex’s CDMO business across India and the UK, partnering with global innovators to fast-track product commercialization and build resilient supply chains. His focus on technology-led growth, customer-centricity, and sustainability has positioned Safex as a trusted partner across global markets.
From pioneering R&D initiatives to driving global expansion and championing EHS practices, Mr. Jindal’s relentless pursuit of excellence continues to shape Safex Group’s future as a forward-thinking, agile, and internationally respected enterprise.
Mr. Piyush Jindal
Joint Managing Director, Safex Group
Mr. Piyush Jindal, a Commerce graduate from Hindu College, Delhi University, and a Chartered Accountant, has been one of the key architects of Safex Group’s exponential rise since 2010. As Joint Managing Director, he has donned multiple hats—driving strategic finance, business expansion, and digital transformation with equal conviction and impact.
Under his leadership, Safex’s market valuation has surged 80x, reflecting his sharp capital allocation mindset and unwavering focus on sustainable growth. Piyush has successfully led four major acquisitions, including a landmark international deal—among the largest in the agchem sector—and has raised over $90 million from leading private equity investors. His ability to forge strong investor relationships and unlock strategic capital has been instrumental in scaling the Group’s global footprint.
Piyush’s expertise goes beyond finance—he has played a central role in defining and executing the Group’s long-term strategy, steering high-stakes decisions on M&A, governance, and global expansion. As a turnaround specialist, he is known for navigating complexity with clarity and aligning business goals with bold, yet pragmatic, execution plans.
He is also the brain behind Safex’s digital transformation, having built an integrated tech platform combining SAP, AI/ML, business analytics, and mobile-first field force automation. This initiative has dramatically improved operational efficiency, visibility, and decision-making across the organization—setting a new benchmark for tech adoption in the agrochemical industry.
His cross-functional leadership across finance, technology, and strategy continues to drive Safex’s evolution into a globally admired, future-ready enterprise.
Other Directors
Raghav Ramdev
Nominee Director
Raghav Ramdev has joined the Board as a nominee director from Chrys Capital. He holds an MBA from the Management Development Institute, Gurgaon, and a Bachelor's degree in Chemical Engineering from Baroda University. Having joined Chrys Capital in Sep 2003, he’s currently a Managing Director and leads investments in the Manufacturing and Healthcare sectors. Previously, he worked with the global research division at McKinsey & Company.
Savan Rashmikant Godiawala
Independent Director
Savan Rashmikant Godiawala is an Independent Director. He holds a PhD in Management, is a Chartered Accountant, a qualified Insolvency Professional, and has a Bachelor's in Law & Commerce. He has over 30 years of experience in Investment Banking and Financial Advisory, including 19 years at Deloitte India, retiring as Partner in March 2024. He teaches at IIM Ahmedabad and IIT Gandhinagar, and co-authored 'Business Taxation' with McGraw Hill.
Prem Chand
Independent Director
Prem Chand, an Independent Director, holds a PhD from BITS Pilani, M.Tech from IIT Madras, and an MBA from ISB Hyderabad. A former Commodore in the Indian Navy, he also served as VP at Tech Mahindra and Director at Codenomicon Software. Currently, he is a consultant at Mitkat Advisory, bringing decades of leadership in defense and private sectors.
Bipinchandra Solanki
Independent Director
Bipinchandra Solanki is an Independent Director with 42+ years of experience in agrochemicals, seeds, and biotech. He has led companies like Syngenta, DevGen, and Monsanto, and has deep expertise in crop segments such as Corn, Cotton, and Hybrid Rice. His leadership spans India and Southeast Asia.
Manisha Raghunath Kadagathur
Independent Director
With over 25 years in HR, Manisha Kadagathur is an Independent Director and a certified coach from ICF. She holds a Bachelor's in Math and Computer Science and an MBA. Currently a Senior Advisor at ANAROCK, she has led HR at companies like GSK, Bharti AXA, and Vini Cosmetics.
Yogesh Kapur
Independent Director
Yogesh Kapur is an Independent Director and a Fellow Chartered Accountant with 39+ years in financial services. He has held key roles at HDFC, HSBC, and Axis Bank. An expert in investment banking and public sector divestments, he has advised the Government of India and led assignments with USAID and the World Bank.
ChrysCapital
Established in 1999, ChrysCapital is a leading India focused investment firm,
managing
approximately $4 billion across eight funds. With over 90 investments since 1999,
the
group has valuable experience investing across a breadth of sectors. ChrysCapital
has
developed a strong track record, delivering over $5.5 billion from over 70 exits.
The
ChrysCapital funds are ranked in the top decile of global private equity funds of
similar
vintage. ChrysCapital VIII, LLC is the eighth fund of the group that was raised in
late
2018 with a corpus of over $850 million.
ChrysCapital believes that partnerships with excellent management teams in
attractive
sectors are the foundation of successful private equity investing. The integrity and
execution capability of management are the two most important factors in the
evaluation of
an investment opportunity. Our aim is to be a trustworthy financial partner and a
stable
long-term investor leveraging our deep relationships in the industry.
One of the factors that differentiates ChrysCapital is the ability to scout and help
its
portfolio companies think through M&A targets. ChrysCapital played an instrumental
role in
Intas’ $770 mn acquisition of Actavis UK / Ireland. ChrysCapital got Intas into the
acquisition process, leveraged industry expertise and relationship with founders to
convince them to pursue the acquisition and eventually helped win the deal for
Intas. This
was the 2nd largest outbound acquisition by an Indian pharma company and propelled
them to
become the second largest generics player in the UK.
Another differentiating factor is ChrysCapital’s industry leading track record,
amongst
private equity peers, of assisting portfolio companies to go public through an IPO –
ChrysCapital has taken 10 companies public such as AU Small Finance Bank, Eris
Lifesciences, Redington, M&M Financial Services, to name a few, and has provided
valuable
inputs to each of these in their IPO journey as well as in their new life as a
publicly-listed company.